Biotech · Private company
Zomagen Biosciences Ltd.
Track this companyFree. Adds Zomagen Biosciences Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- VTX2735Phase 2 · Cryopyrin Associated Periodic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- VTX2735Phase 2 · Recurrent PericarditisClinicalTrials.gov · fetched Nov 12, 2026
- VTX3232Phase 2 · Idiopathic Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- VTX3232 30 mgPhase 2 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- VTX3232 30 mg in combination with semaglutidePhase 2 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- An Open-Label Pilot Study of VTX2735 in Recurrent PericarditisPHASE2 · RECRUITING · started Jan 28, 2025ClinicalTrials.gov NCT06836232 · fetched Nov 12, 2026
- Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in ObesityPHASE2 · COMPLETED · started Jan 7, 2025ClinicalTrials.gov NCT06771115 · fetched Nov 12, 2026
- Phase 2a Study of VTX3232 in Parkinson's DiseasePHASE2 · COMPLETED · started Aug 8, 2024ClinicalTrials.gov NCT06556173 · fetched Nov 12, 2026
- A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic SyndromePHASE2 · COMPLETED · started Mar 18, 2023ClinicalTrials.gov NCT05812781 · fetched Nov 12, 2026